IRIS
NOBBIO, LUCILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.244
Totale 6.244
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.244
Totale 6.244
Salva come PNG Salva come JPEG
Città #
Genova 4.255
Rapallo 762
Genoa 657
Vado Ligure 553
Bordighera 17
Totale 6.244
Salva come PNG Salva come JPEG
Nome #
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 157
Does parkin play a role in the peripheral nervous system? A family report 151
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies 151
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A 147
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 144
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 140
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 139
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22 137
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. 132
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 132
Mifepristone (RU 38486) influences expression of glycoprotein Po and morphological parameters at the level of rat sciatic nerve: In vivo observations . 131
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. 127
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 126
Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein. 126
Mitichondrial dysfunction in experimental Charcot-marie-Tooth type 1° (CMTIA) neuropathy: a possible key factor for the axonal degeneration 122
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 122
Inherited Peripheral Neuropathies 122
Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy 122
Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease 121
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 120
Synaptopodin and 4 novel genes identified in primary sensory neurons. 118
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 118
Correlation among demyelination and axonal degeneration: a new trophic role for myelin sheath 111
P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy 105
Tyrosine kinase A-Nerve Growth Factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. 104
Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy 103
P2X7 antagonists improve “in vitro” myelination in organotypic dorsal root ganglia (DRG) cultures from a rat model of CMT1A neuropathy 102
PMP22 messenger RNA levels in skin biopsies: Testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker 101
Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy. 99
P2X7 antagonism in experimental CMT1A: a potential therapeutic strategy 98
Oxydative phosphorilation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy 96
Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7. 95
Role of the P2X7 receptor in the altered calcium homeostasis of Schwann cells overexpressing peripheral myelin protein 22 92
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 91
Energetic disfunction in CMT1A: role of myelin and neuron mitochondria 90
P2X7 overexpression is responsible for the increased intracellular calcium and functional derangement in Schwann cells from rats with Charcot-Marie-Tooth type 1A neurophaty. 89
Energy supply and demyelinising diseases: a new trophic role of myelin sheath. 89
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial 89
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial 88
P2X7 overexpression is responsible for the increased intracellular calcium and functional derangement in Schwann cells from rats with Charcot-Marie-Tooth type 1A neuropathy. 87
Energetic metabolism of myelinated axons: a new correlation among axonal degeneration, demyelination and energy supply. 87
P2X7 antagonists improve “in vitro” myelination in organotypic dorsal root ganglia (DRG) cultures from a rat model of CMT1A neuropathy 87
The transcription factors EBF1 and EBF2 are positive regulators of myelination in Schwann cells 86
Ebf Genes In Peripheral Nerve Myelination 85
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 84
The diadenosine homodinucleotide P18 improvesin vitromyelination in experimental Charcot-Marie-Tooth type 1A 82
Vitamin C and Charcot-Marie-Tooth 1A: Pharmacokinetic considerations 80
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 78
Functional Characterization of Hyccin, a Novel Membrane Protein Involved in Central and Peripheral Myelination 72
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 71
P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 70
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 69
Ebf genes' silencing impairs myelin formation 68
P2X7 TARGETING IMPROVES IN VITRO MYELINATION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 67
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years 66
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial. 64
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 62
Role of the P2X7 receptor in the altered calcium homeostasis of Schwann cells overexpressing peripheral myelin protein 22 (PMP22) 60
Neuropatie di Charcot-Marie-Tooth: dalla patologia alla patogenesi 55
Inherited neuropathies. 55
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 48
null 48
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment 43
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism 32
DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS 25
Techniques for the standard histological and ultrastructural assessment of nerve biopsies 15
Guillain barré syndrome of axonal type in a multple sclerosis patient: Fortuitous association or linked disorders? 14
Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients 11
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 10
Totale 6.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.877
article - articoli 15.406
book - libri 0
conference - conferenze 4.146
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 325
Totale 39.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.088 0 0 0 0 0 167 252 88 113 271 146 51
2020/2021331 24 37 20 36 16 25 22 32 32 28 29 30
2021/2022756 16 69 51 86 20 48 44 186 32 63 31 110
2022/2023885 74 82 7 83 173 132 2 81 139 6 94 12
2023/2024494 31 51 15 63 36 85 58 39 22 10 23 61
2024/2025623 96 83 52 104 167 121 0 0 0 0 0 0
Totale 6.328